Optibiotix Health (OPTI)

 

OPTI Share PerformanceMore

52 week high90.00 03/04/17
52 week low52.00 16/08/17
52 week change -4.50 (-6.43%)
4 week volume7,133,623 29/08/17

Media for (OPTI)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Technical, regulatory & commercial update

RNS Number: 0749R OptiBiotix Health PLC 19 September 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") SlimBiome: Technical, Regulatory and Commercial Update OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, provides the follo...

OptiBiotix Health signs MoU with Bened Biomedical

OptiBiotix Health signed a Memorandum of Understanding (MoU) with Bened Biomedical, Taiwan. The MoU sets the fram...

Strategic partnership with Bened Biomedical

RNS Number: 5525Q OptiBiotix Health PLC 13 September 2017 OptiBiotix Health plc ("OptiBiotix" or "the Company") Strategic partnership with Bened Biomedical OptiBiotix Health Plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has signed a Memorandum of Understanding ("MoU") with Bened Biomed...

Holding(s) in Company

RNS Number: 3593Q OptiBiotix Health PLC 11 September 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Optibiotix He...

Invited to present at Expoquimia in Barcelona

RNS Number: 0312Q OptiBiotix Health PLC 07 September 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") OptiBiotix invited to present at Expoquimia in Barcelona OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, cardiovascular disease and d ia b ete s, a nn o un ces it has been inv...

Investor evening

RNS Number: 9507P OptiBiotix Health PLC 06 September 2017 O p t i B i o t i x H eal th p l c ( "O p t i Bi o t i x" o r " t h e C o m pan y" ) Investor evening OptiB i o t i x H ealth p l c (A I M: O P T I ), a li f e sc i ences bu s i n ess d e v e l o p i n g products to tac k l e o b esi t y , h i g h chole s t e r o l a n d d ia b e t e s , announces that Stephen O'Hara, CEO of Optibiotix...

Manufacturing Agreement with Tata Chemicals

RNS Number: 7814P OptiBiotix Health PLC 05 September 2017 O p t i B i o t i x H eal th p l c ( "O p t i Bi o t i x" o r " t h e C o m pan y" ) Scale up and Manufacturing Agreement with Tata Chemicals OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a scale ...

Exercise of Options and Issue of Equity

RNS Number: 6268P OptiBiotix Health PLC 01 September 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") Exercise of Option and Issue of Equity OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces that the Company has received notification from David Evans, to exe...

Fundamental DataMore

EPS-1.67
Dividend yield0 %

Equity Research (OPTI)

OptiBiotix Health plc
25/07/2017
Coverage of the equity securities of the following companies has been discontinued. Investors should no longer rely upon our previously published reports, recommendations, price targets or estimates...
OptiBiotix Health plc
30/08/2016
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has reported another half (to May 2016) of strong scientific and commercial progress. Operational...
OptiBiotix Health plc
28/07/2016
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has announced the successful completion of a trial launch for its Slimbiome® ingredients in a range of...

Latest discussion posts More

  • SOH 220917

    http://www.proactiveinvestors.co.uk/companies/news/184447/optibiotix-health-lines-up-the-targets-for-its-precision-microbiome-engineering-184447.html mol
    22-Sep-2017
    mol42
  • Re: Shareholder selling

    alpal, With respect, as you probably know, David Evans was Chairman of the OPTI Board until ill health caused him to stand down. He was "in" from the outset with Adam ...
    18-Sep-2017
    Novy kluk
  • Re: Shareholder selling

    Or it could simply be he just exercised options at 8p so he's made 900% profit in a few days. Plus he still has over 2m shares for the longer run. Relax .. I won't believe ...
    11-Sep-2017
    The Speculator

Users' HoldingsMore

Users who hold Optibiotix Health also hold..
LLOYDS GRP.20%
SIRIUS MINERALS11%
NATIONAL GRID10%
PREMAITHA9%
BP9%

Codes & Symbols

ISINGB00BP0RTP38
SymbolsOPTI, LSE:OPTI, OPTI.L, OPTI:LN, LON:OPTI, XLON:OPTI